Effective CKD care in european countries: Challenges and opportunities for health policy

American Journal of Kidney Diseases

Volumn 65, Issue 1, 2015, Pages 15-25

  Bello, Aminu K ^a   Levin, Adeera ^b   Manns, Braden J ^c   Feehally, John ^d   Drueke, Tilman ^e   Faruque, Labib ^a   Hemmelgarn, Brenda R ^c   Kernahan, Charles ^f   Mann, Johannes ^g   Klarenbach, Scott ^a   Remuzzi, Giuseppe ^h   Tonelli, Marcello ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^f Department of Health   (United Kingdom)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Chronic kidney disease (CKD); Chronic noncommunicable disease (NCD); Europe; Health systems; Kidney Health for Life (KH4L); Non dialysis dependent CKD; Organization; Policy; care structures; Public health

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DISEASE SURVEILLANCE; EUROPE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; INTERNATIONAL COOPERATION; KIDNEY FAILURE; MEDICAL INFORMATION SYSTEM; MEDICAL SERVICE; NEPHROLOGIST; NON COMMUNICABLE DISEASE; PATIENT MONITORING; POPULATION; RENAL REPLACEMENT THERAPY; RISK FACTOR; WORLD HEALTH ORGANIZATION; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE SURVEY; HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PROCEDURES; PUBLIC HEALTH; RENAL INSUFFICIENCY, CHRONIC; SECONDARY PREVENTION; STANDARDS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

COST-BENEFIT ANALYSIS; DISEASE PROGRESSION; EUROPE; HEALTH CARE SURVEYS; HEALTH POLICY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNATIONAL COOPERATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT CARE MANAGEMENT; PUBLIC HEALTH; RENAL INSUFFICIENCY, CHRONIC; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84922375162     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.07.033     Document Type: Article

References (110)

1. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011; 80 (12): 1258-1270
2. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: Global dimension and perspectives. Lancet. 2013; 382 (9888): 260-272
3. Chronic Kidney Disease Prognosis Consortium; Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet. 2010; 375 (9731): 2073-2081
4. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010; 375 (9722): 1296-1309
5. El Nahas AM, Bello AK. Chronic kidney disease: The global challenge. Lancet. 2005; 365 (9456): 331-340
6. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int. 2011; 80 (1): 17-28
7. Anonymous. The global issue of kidney disease. Lancet. 2013; 382 (9887): 101
8. Feehally J. Chronic kidney disease: Health burden of kidney disease recognized by UN. Nat Rev Nephrol. 2012; 8 (1): 12-13
9. Luyckx VA, Naicker S, McKee M. Equity and economics of kidney disease in sub-Saharan Africa. Lancet. 2013; 382 (9887): 103-104
10. Levin A, Perkovic V. Epidemiology: Global Burden of Disease Study 2010: implications for nephrology. Nat Rev Nephrol. 2013; 9 (4): 195-197
11. Picker Institute. Picker principles of patient-centered care. 1987. http://pickerinstitute.org/about/picker-principles/. Accessed November 14, 2013
12. European Kidney Patients' Federation. Do renal patients receive the required information to make an informed choice? 2013. http://www.ceapir.org/activities/surveys/. Accessed November 14, 2013
13. European Heart Health Charter. European Heart Charter Questionnaire. 2007. www.heartcharter.org/about-charter/default. aspx. Accessed November 14, 2013
14. Mackenbach JP, Karanikolos M, McKee M. The unequal health of Europeans: Successes and failures of policies. Lancet. 2013; 381 (9872): 1125-1134
15. World Health Organization. Innovative care for chronic conditions building blocks for action. 2002. http://site.ebrary.com/id/10039191. Accessed November 10, 2013
16. World Health Organization. Health 2020: A European policy framework supporting action across government and society for health and well-being. 2012. http://www.euro.who.int/en/healthtopics/health-policy/health-2020-the-european-policy-for-healthand-well-being/about-health-2020. Accessed October 29, 2013
17. Stevens PE, Levin A. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 clinical practice guideline. Ann Intern Med. 2013; 158 (11): 825-830
18. Lamb EJ. United Kingdom guidelines for chronic kidney disease. Scand J Clin Lab Invest Suppl. 2008; 68 (suppl 241): 16-22
19. Kidney Health Australia. The aim of the KHA-CARI Guidelines 2013; http://www.kidney.org.au/HealthProfessionals/KHACARIGuidelines/tabid/637/Default.aspx. Accessed October 31, 2013
20. World Health Organization. Global action plan for the prevention and control of NCDs 2013-2020. 2013. http://www. who.int/nmh/en/. Accessed November 12, 2013
21. Wright Nunes JA. Education of patients with chronic kidney disease at the interface of primary care providers and nephrologists. Adv Chronic Kidney Dis. 2013; 20 (4): 370-378
22. Shahinian VB, Saran R. The role of primary care in the management of the chronic kidney disease population. Adv Chronic Kidney Dis. 2010; 17 (3): 246-253
23. Israni RK, Shea JA, Joffe MM, Feldman HI. Physician characteristics and knowledge of CKD management. Am J Kidney Dis. 2009; 54 (2): 238-247
24. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: A national study. Am J Kidney Dis. 2006; 48 (2): 192-204
25. Fox CH, Brooks A, Zayas LE, McClellan W, Murray B. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: An Upstate New York Practice-Based Research Network (UNYNET) study. J Am Board Fam Med. 2006; 19 (1): 54-61
26. Frimat L, Siewe G, Loos-Ayav C, Briancon S, Kessler M, Aubrege A. [Chronic kidney disease: Do generalists and nephrologists differ in their care?] Nephrol Ther. 2006; 2 (3): 127-135
27. Orte Martinez L, Barril Cuadrado G. [Advanced chronic kidney disease unit. Concept of a multidisciplinary unit. Objectives of the CKD unit]. Nefrologia. 2008; 28 (suppl 3): 49-52
28. Mendelssohn DC, Toffelmire EB, Levin A. Attitudes of Canadian nephrologists toward multidisciplinary team-based CKD clinic care. Am J Kidney Dis. 2006; 47 (2): 277-284
29. Valderrabano F, Golper T, Muirhead N, Ritz E, Levin A. Chronic kidney disease: Why is current management uncoordinated and suboptimal? Nephrol Dial Transplant. 2001; 16 (suppl 7): 61-64
30. National Health Service Information Centre for Health and Social Care. Quality and Outcomes Framework. 2013. http://www. hscic.gov.uk/qof. Accessed October 31, 2013
31. Stevens PE, O'Donoghue DJ. The UK model for system redesign and chronic kidney disease services. Semin Nephrol. 2009; 29 (5): 475-482
32. Stevens PE, de Lusignan S, Farmer CK, Tomson CR. Engaging primary care in CKD initiatives: The UK experience. Nephrol Dial Transplant. 2012; 27 (suppl 3): iii5-iii11
33. Delanaye P, Cavalier E, Saint-Remy A, Lutteri L, Krzesinski JM. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population. Scand J Clin Lab Invest. 2009; 69 (3): 344-349
34. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G. Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. The Copenhagen City Heart Study Group. Scand J Clin Lab Invest. 1993; 53 (8): 867-872
35. Juutilainen A, Kastarinen H, Antikainen R, et al. Comparison of the MDRD Study and the CKD-EPI study equations in evaluating trends of estimated kidney function at population level: findings from the National FINRISK Study. Nephrol Dial Transplant. 2012; 27 (8): 3210-3217
36. Stengel B, Metzger M, Froissart M, et al. Epidemiology and prognostic significance of chronic kidney disease in the elderly-The Three-City prospective cohort study. Nephrol Dial Transplant. 2011; 26 (10): 3286-3295
37. Liese AD, Hense HW, Doring A, Stieber J, Keil U. Microalbuminuria, central adiposity and hypertension in the nondiabetic urban population of the MONICA Augsburg survey 1994/95. J Hum Hypertens. 2001; 15 (11): 799-804
38. Browne GM, Eustace JA, Fitzgerald AP, Lutomski JE, Perry IJ. Prevalence of diminished kidney function in a representative sample of middle and older age adults in the Irish population. BMC Nephrol. 2012; 13 (144): 1-9
39. Gambaro G, Yabarek T, Graziani MS, et al. Prevalence of CKD in Northeastern Italy: Results of the INCIPE study and comparison with NHANES. Clin J Am Soc Nephrol. 2010; 5 (11): 1946-1953
40. Hillege HL, Janssen WM, Bak AA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001; 249 (6): 519-526
41. Hallan SI, Dahl K, Oien CM, et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ. 2006; 333 (7577): 1047
42. Vinhas J, Gardete-Correia L, Boavida JM, et al. Prevalence of chronic kidney disease and associated risk factors, and risk of end-stage renal disease: Data from the PREVADIAB study. Nephron Clin Pract. 2011; 119 (1): C35-c40
43. Nitsch D, Felber Dietrich D, von Eckardstein A, et al. Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: Results of the Swiss SAPALDIA study. Nephrol Dial Transplant. 2006; 21 (4): 935-944
44. Otero A, de Francisco A, Gayoso P, Garcia F. EPIRCE Study Group. Prevalence of chronic renal disease in Spain: Results of the EPIRCE study. Nefrologia. 2010; 30 (1): 78-86
45. Suleymanlar G, Utas C, Arinsoy T, et al. A populationbased survey of Chronic REnal Disease In Turkey-The CREDIT study. Nephrol Dial Transplant. 2011; 26 (6): 1862-1871
46. Stevens PE, O'Donoghue DJ, de Lusignan S, et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007; 72 (1): 92-99
47. Kearns B, Gallagher H, de Lusignan S. Predicting the prevalence of chronic kidney disease in the English population: A cross-sectional study. BMC Nephrol. 2013; 14: 49
48. Kerr M, Bray B, Medcalf J, O'Donoghue DJ, Matthews B. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012; 27 (suppl 3): iii73-iii80
49. Parikh PB, Yang J, Leigh S, et al. The impact of financial barriers on access to care, quality of care and vascular morbidity among patients with diabetes and coronary heart disease. J Gen Intern Med. 2014; 29 (1): 76-81
50. Rahimi AR, Spertus JA, Reid KJ, Bernheim SM, Krumholz HM. Financial barriers to health care and outcomes after acute myocardial infarction. JAMA. 2007; 297 (10): 1063-1072
51. OCED Publishing. Health care systems: Efficiency and policy settings. 2010. http://www.oecd.org/eco/healthcaresy stemsefficiencyandpolicysettings.htm. Accessed July 7, 2014
52. OCED Publishing. OECD health data 2011. http://stats. oecd.org/index.aspx. Accessed November 14, 2013
53. Karanikolos M, Mladovsky P, Cylus J, et al. Financial crisis, austerity, and health in Europe. Lancet. 2013; 381 (9874): 1323-1331
54. Saltman RB, Cahn Z. Restructuring health systems for an era of prolonged austerity: An essay by Richard B Saltman and Zachary Cahn. BMJ. 2013; 346: f3972
55. McClure ML. The nurse executive. In praise of leadership longevity. J Prof Nurs. 1990; 6 (4): 194, 246
56. The National Collaborating Centre for Chronic Conditions (UK). Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care. London, UK: Royal College of Physicians of London 2008
57. Health Services Executive. The National Renal Office. 2012. http://www.hse.ie/eng/about/Who/NRO. Accessed November 14, 2013
58. Helsedirektoratet. Handlingsplan for forebygging og behandling av kronisk nyresykdom (2011-2015). Action plan for the prevention and treatment of chronic kidney disease (2011-2015), Ministry of Health, Oslo, Norway, 2011. http://helsedirektoratet.no/publikasjoner/handlingsplan-for-forebygging-og-behandling-avkronisk-nyresykdom-2011-2015. Accessed November 13, 2013
59. Jean G, Chazot C. [The French clinician's guide to the Kidney Disease: Improving Global Outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)]. Nephrol Ther. 2010; 6 (3): 151-157
60. Meijer LJ, Schellevis F. [Referring patients with chronic renal failure: Differences in referral criteria between hospitals] [abstract]. Ned Tijdschr Geneeskd. 2012; 156 (50): A5259
61. Flores JC, Alvo M, Borja H, et al. [Clinical guidelines on identification, management and complications of chronic kidney disease]. Rev Med Chile. 2009; 137 (1): 137-177
62. Anonymous. Irish College of General Practitioners. Chronic Kidney Disease: Information Pack. http://www.icgp.ie/go/library/catalogue/item?spId=B49C4B92-4CFF-4AB1-A81B86 E51F816436. Accessed October 28, 2014
63. Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association and the Royal College of General Practitioners. Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral. London, UK: Royal College of Physicians; 2006
64. Locatelli F, Zoccali C; SIR SIN Study Investigators. Clinical policies on the management of chronic kidney disease patients in Italy. Nephrol Dial Transplant. 2008; 23 (2): 621-626
65. Fraser SD, Roderick PJ, McIntyre NJ, et al. Suboptimal blood pressure control in chronic kidney disease stage 3: Baseline data from a cohort study in primary care. BMC Fam Pract. 2013; 14: 88
66. Hans Mak Instituut. Improving the quality of care. 2013. http://www.hansmakinstituut.nl/. Accessed November 14, 2013
67. Fraser SD, Roderick PJ, McIntyre NJ, et al. Socioeconomic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3. Nephron Clin Pract. 2012; 122 (1-2): 58-65
68. Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: Applications and implications. Am J Kidney Dis. 2009; 53 (3) (suppl 3): S4-S16
69. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67 (6): 2089-2100
70. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011; 377 (9775): 1438-1447
71. Geneau R, Stuckler D, Stachenko S, et al. Raising the priority of preventing chronic diseases: A political process. Lancet. 2010; 376 (9753): 1689-1698
72. Beaglehole R, Bonita R, Horton R. Independent global accountability for NCDs. Lancet. 2013; 381 (9867): 602-605
73. Beaglehole R, Bonita R, Horton R, et al. Measuring progress on NCDs: One goal and five targets. Lancet. 2012; 380 (9850): 1283-1285
74. Beaglehole R, Bonita R; Lancet NCD Action Group. Tackling NCDs: A different approach is needed [letter]. Lancet. 2012; 379 (9829): 1873. author reply 1873-1874
75. Beaglehole R, Bonita R, Alleyne G, Horton R. NCDs: Celebrating success,moving forward. Lancet. 2011; 378 (9799): 1283-1284
76. Beaglehole R, Bonita R, Alleyne G, et al. UN high-level meeting on non-communicable diseases: Addressing four questions. Lancet. 2011; 378 (9789): 449-455
77. Beaglehole R, Horton R. Chronic diseases: Global action must match global evidence. Lancet. 2010; 376 (9753): 1619-1621
78. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention. Lancet. 2013; 382 (9889): 339-352
79. Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences. Am J Kidney Dis. 2010; 55 (3): 452-462
80. Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis. 2010; 55 (3): 463-473
81. Manns B, Hemmelgarn B, Tonelli M, et al. Population based screening for chronic kidney disease: Cost effectiveness study. BMJ. 2010; 341: C5869
82. Karunaratne K, Stevens P, Irving J, et al. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5. Nephrol Dial Transplant. 2013; 28 (8): 2107-2116
83. Pellegrino B, Schmidt RJ. Why work together? Developing effective comanagement strategies for the care of patients with CKD. Adv Chronic Kidney Dis. 2011; 18 (6): 396-399
84. Coritsidis GN, Linden E, Stern AS. The role of the primary care physician in managing early stages of chronic kidney disease. Postgrad Med. 2011; 123 (5): 177-185
85. Master RJ, Feltin M, Jainchill J, et al.Acontinuum of care for the inner city: Assessment of its benefits for Boston's elderly and high-risk populations. N Engl J Med. 1980; 302 (26): 1434-1440
86. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: A randomised controlled study. Lancet. 1999; 354 (9184): 1077-1083
87. Chen YR, Yang Y, Wang SC, et al. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: A 3-year prospective cohort study. Nephrol Dial Transplant. 2013; 28 (3): 671-682
88. World Health Organization. WHO Recommendations: Optimizing Health Worker Roles to Improve Access to Key Maternal and Newborn Health Interventions Through Task Shifting. Geneva, Switzerland: WHO 2012
89. Gregorio LE, Gregorio DI. Polity and health care expenditures: The association among 159 nations. J Epidemiol Global Health. 2013; 3 (1): 49-57
90. Walker N, Bankart J, Brunskill N, Baker R. Which factors are associated with higher rates of chronic kidney disease recording in primary care? A cross-sectional survey of GP practices. Br J Gen Pract. 2011; 61 (584): 203-205
91. Hobbs H, Stevens P, Klebe B, et al. Referral patterns to renal services: What has changed in the past 4 years? Nephrol Dial Transplant. 2009; 24 (11): 3411-3419
92. Remuzzi G, Benigni A, Finkelstein FO, et al. Kidney failure: Aims for the next 10 years and barriers to success. Lancet. 2013; 382 (9889): 353-362
93. Alwan A, Maclean DR, Riley LM, et al. Monitoring and surveillance of chronic non-communicable diseases: Progress and capacity in high-burden countries. Lancet. 2010; 376 (9755): 1861-1868
94. Saran R, Hedgeman E, Huseini M, Stack A, Shahinian V. Surveillance of chronic kidney disease around the world: Tracking and reining in a global problem. Adv Chronic Kidney Dis. 2010; 17 (3): 271-281
95. Plantinga LC, Crews DC, Coresh J, et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010; 5 (4): 673-682
96. Shahinian VB, Hedgeman E, Gillespie BW, et al. Estimating prevalence of CKD stages 3-5 using health system data. Am J Kidney Dis. 2013; 61 (6): 930-938
97. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012; 379 (9811): 165-180
98. McBride D, Dohan D, Handley MA, Powe NR, Tuot DS. Developing a CKD registry in primary care: Provider attitudes and input. Am J Kidney Dis. 2014; 63 (4): 577-583
99. Hostetter TH, Kochis DJ, Shaffer RN, et al. World Kidney Day 2011. J Am Soc Nephrol. 2011; 22 (3): 397-398
100. McCarthy M. Targets for health in Europe: The debate continues. Eur J Public Health. 2012; 22 (4): 455-456
101. Greer SL, Hervey TK, Mackenbach JP, McKee M. Health law and policy in the European Union. Lancet. 2013; 381 (9872): 1135-1144
102. Tonelli M, Agarwal S, Cass A, et al.Howto advocate for the inclusion of chronic kidney disease in a national noncommunicable chronic disease program. Kidney Int. 2014; 85: 1269-1274
103. Arogundade FA, Barsoum RS. CKD prevention in sub-Saharan Africa: A call for governmental, nongovernmental, and community support. Am J Kidney Dis. 2008; 51 (3): 515-523
104. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006; 354 (10): 997-999
105. Crews DC, Liu Y, Boulware LE. Disparities in the burden, outcomes, and care of chronic kidney disease. Curr Opin Nephrol Hypertens. 2014; 23 (3): 298-305
106. Tuttle KR, Tuot DS, Corbett CL, Setter SM, Powe NR. Type 2 translational research for CKD. Clin J Am Soc Nephrol. 2013; 8 (10): 1829-1838
107. Samuels JA, Molony DA. Randomized controlled trials in nephrology: State of the evidence and critiquing the evidence. Adv Chronic Kidney Dis. 2012; 19 (1): 40-46
108. Palmer SC, Sciancalepore M, Strippoli GF. Trial quality in nephrology: How are we measuring up? Am J Kidney Dis. 2011; 58 (3): 335-337
109. Eckardt KU, Coresh J, Devuyst O, et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013; 382 (9887): 158-169
110. Public Health England. NHS Health Check Implementation Review and Action Plan. Public Health England, London; 2013. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/224805/NHS-Health-heck-implementation-review-and-action-plan.pdf. Accessed November 14, 2013.